• Recherche

Publications IICiMed 2006

Abdala, H.; David, S.; Bekesi, G.; Fellous, A.; Kalil, J.; Le Pape, P. Microtubule target for new antileishmanial drugs refered as ethyl 3-haloacetamidobenzoates. J. Enz. Inhib. Med. Chem. 2006, 21, 305-312.


P48. Giraud, F., Logé, C.; Le Borgne, M.; Pagniez, F.; Na, Y.M.; Le Pape, P. 3D-QSAR COMSIA study on 3-azolylmethylindoles as anti-leishmanial agents. SAR and QSAR in Environ. Res. 2006, 17, 299-309.


P49. Lardic, M.; Patry, C.; Duflos, M.; Guillon, J.; Massip, S.; Cruzalegui, F.; Edmonds, T.; Giraudet, S.; Marini, L.; Leonce, S. Synthesis and primary cytotoxicity evaluation of arylmethylenenaphthofuranone derivatives.J. Enz. Inh. Med. Chem. 2006, 21, 313-325.

P50. Lebouvier, N.; Giraud, F.; Corbin, T.; Na, Y.M.; Le Baut, G.; Marchand, P.; Le Borgne, M. Efficient microwave-assisted synthesis of 2-phenyl-1-(1H-indol-1-yl)-3-(1H-1,2,4-triazol-1-yl)propan-2-ol derivatives with potential antifungal activity. Tetrahedron Lett. 2006, 47, 6479-6483.


P51. Lézé, M-P.; Le Borgne, M.; Pinson, P.; Palusczak, A.; Duflos, M.; Le Baut, G.; Hartmann, R.W. Synthesis and biologicol evaluation of 5-[(aryl)(1H-imidazol-1-yl)methyl]-1H-indoles: Potent and selective aromatase inhibitors. Bioorg. Med. Chem. Lett. 2006, 16, 1134-1137.

P52. Pagniez, F.; Marchand, P.; Abdala, H.; Le Borgne, M.; Robert-Piessard, S.; Le Pape, P. 3-(a-Azolylbenzyl)indoles: in vitro and in vivo anti-Leishmania activity and mechanism of action. J. Enz. Inh. Med. Chem. 2006, 21, 277-283.

P53. Testard, A.; Logé, C.; Léger, B.; Robert, J-M.; Lozach, O.; Blairvacq, M.; Meijer, L.; Thiéry, V.; Besson, T. Thiazolo[5,4-f]quinazolin-9-ones, inhibitors of glycogen synthase kinase-3. Bioorg. Med. Chem. Lett. 2006, 16, 3419-3423.

Mis à jour le 02 octobre 2013 - Céline LHOMELET.